Khaoula Mazouzi, Oncologist, Bone Marrow Transplantation and Cellular Therapyst at MD Anderson Cancer Center, shared a post by OncoDaily, adding:
“I was delighted to speak today at the LeukO Global Virtual Congress 2026 and contribute to this truly global exchange in leukemia care.
During my presentation, ‘CAR-T in ALL: Who, When, and What Comes Next?’, I discussed how we can better define the role and timing of CAR-T therapy in acute lymphoblastic leukemia, and how the field may continue to evolve.
My sincere thanks to OncoDaily and for the wonderful team behind it Arpi Asminian, Emma Tadevosyan and Inessa Mkhitaryan for the invitation and for creating a platform that brings together experts and colleagues from around the world to share knowledge, challenge current thinking, and advance the care of patients with leukemia.
It was a privilege to be part of LeukO 2026, and I look forward to contributing to future OncoDaily congresses and conversations.”
Quoting OncoDaily:
“Day 1 of LeukO 2026 is officially complete!
Today, LeukO 2026 brought together experts, clinicians, and researchers from across the world for a full day of conversations, shared experiences, and international exchange.
And we’re not done yet.
LeukO 2026 continues tomorrow with another full day of discussions and perspectives from the global leukemia community.
For now, take a look back at the highlights from Day 1 on OncoDaily.”
You can also read ‘Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 2‘
